OpenMedicare
Start Here
Explore
Fraud
Investigations
Data
Tools
About

Footer

OpenMedicare

Independent Medicare data journalism

Sister Sites

  • OpenMedicaid
  • OpenFeds
  • OpenSpending

Explore

  • Providers
  • Procedures
  • States
  • Specialties
  • Search

Fraud Analysis

  • Still Out There (AI)
  • Fraud Overview
  • Fraud Watchlist
  • Deep Dive Profiles
  • Impossible Numbers
  • Report Fraud

Investigations

  • The Algorithm Knows
  • How We Built the Model
  • Internal Medicine Crisis
  • Florida & California Fraud
  • Million Dollar Flagged
  • All Investigations

Tools

  • Provider Lookup
  • Compare
  • Cost Calculator
  • Your Medicare Dollar
  • Downloads

About

  • About OpenMedicare
  • Methodology
  • Glossary
  • Data Sources
  • API Docs
  • Updates
Data Sources: Centers for Medicare & Medicaid Services (CMS), Medicare Provider Utilization and Payment Data
Disclaimer: This site is an independent journalism project. Data analysis and editorial content are not affiliated with or endorsed by CMS or any government agency. All spending figures are based on publicly available Medicare payment records.
Sister Sites: OpenMedicaid ยท OpenFeds ยท OpenSpending

ยฉ 2026 OpenMedicare. Independent data journalism. Built by TheDataProject.ai

Methodologyโ€ขDownload Data
  1. Home
  2. Providers
  3. Amy Law
๐ŸŽ—๏ธ
MDIndividual

Amy Law, M.D.

NPI: 1861452054
Rancho Mirage, CA
10 years of data
Hematology-Oncology
$34.4M
Total Payments
440
Beneficiaries
3.4M
Services
2.49x
Markup Ratio

Peer Comparison

99th
percentile in specialty
This provider$34.4M
Specialty median$339.6K
Rank #51 of 60 in specialty

๐Ÿ“‹ Key Findings

1Billed $34.4M over 10 years
22.49x markup ratio (above median)
399th percentile in Hematology-Oncology by payments
41.4K services/day โ€” physically implausible
53 procedures with >3x markup

โš ๏ธ This provider averages 1.4K services per working day โ€” physically unusual for an individual practitioner

Based on 3.4M total services over 10 years (250 working days/year). Learn about impossible service volumes โ†’

๐Ÿ”Ž Data Analysis

This provider's $34.4M in total Medicare payments ranks in the 99th percentile of Hematology-Oncology providers nationally.

Averaging 1.4K services per working day raises questions about billing patterns.

Medicare payments to this provider grew 81% from 2014 to 2023.

AI-generated analysis based on Medicare payment data.

Annual Medicare Payments

Annual Services Provided

Avg Payment per Service

Markup Ratio Over Time

Submitted Charges vs. Medicare Payments

Average per-service amounts submitted by the provider compared to what Medicare actually paid โ€” the gap represents the markup.

YearAvg SubmittedAvg PaidMarkup RatioGap per ServiceTotal PaymentsServicesBeneficiaries
2014$16.42$8.202.00x$8.22$2.2M268.8K44
2015$13.75$7.991.72x$5.76$1.9M233.7K38
2016$14.57$8.751.67x$5.82$2.5M283.8K41
2017$16.23$8.841.84x$7.39$3.5M397.3K43
2018$21.59$10.822.00x$10.77$3.6M332.3K42
2019$19.60$9.742.01x$9.86$3.6M368.9K44
2020$23.58$10.672.21x$12.91$3.9M369.6K45
2021$37.58$11.903.16x$25.68$4.7M390.9K47
2022$34.77$10.673.26x$24.10$4.5M424.9K49
2023$39.83$10.833.68x$29.00$4.0M368.2K47

Top Procedures (20)

J9271Injection, pembrolizumab, 1 mgโš  3.0x markup
$5.2M
127.8K services$40.33/svc3.01x markup
J0897Injection, denosumab, 1 mg
$4.3M
291.5K services$14.87/svc2.24x markup
J9299Injection, nivolumab, 1 mg
$3.2M
140.8K services$22.72/svc2.91x markup
J9310Injection, rituximab, 100 mg
$2.8M
4.5K services$615.71/svc1.32x markup
J1569Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg
$2.3M
72.1K services$32.41/svc2.21x markup
J9312Injection, rituximab, 10 mg
$2.0M
27.7K services$72.20/svc2.25x markup
J0885Injection, epoetin alfa, (for non-esrd use), 1000 units
$1.5M
177.6K services$8.47/svc2.48x markup
J9035Injection, bevacizumab, 10 mg
$1.2M
21.8K services$56.62/svc1.45x markup
J1568Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
$1.1M
32.0K services$32.88/svc2.89x markup
99214Established patient office or other outpatient visit, 30-39 minutes
$997.9K
11.0K services$90.95/svc2.43x markup
96413Administration of chemotherapy into vein, 1 hour or less
$906.9K
7.8K services$116.48/svc2.41x markup
J1439Injection, ferric carboxymaltose, 1 mg
$867.0K
1.0M services$0.85/svc2.35x markup
99213Established patient office or other outpatient visit, 20-29 minutes
$684.2K
11.6K services$58.77/svc2.15x markup
Q5118Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mgโš  4.4x markup
$614.5K
18.7K services$32.83/svc4.37x markup
J9395Injection, fulvestrant, 25 mgโš  3.0x markup
$612.4K
14.8K services$41.24/svc3.01x markup
J9041Injection, bortezomib (velcade), 0.1 mg
$501.5K
14.3K services$35.15/svc2.40x markup
J9055Injection, cetuximab, 10 mg
$437.7K
9.8K services$44.80/svc1.67x markup
96365Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
$375.8K
6.5K services$57.82/svc2.35x markup
J2505Injection, pegfilgrastim, 6 mg
$340.2K
100 services$3.4K/svc1.45x markup
99205New patient office or other outpatient visit, 60-74 minutes
$275.4K
1.7K services$164.24/svc2.10x markup
Show detailed table โ–พ
CodeDescriptionServicesPaymentsAvg/ServiceMarkup
J9271Injection, pembrolizumab, 1 mg127.8K$5.2M$40.333.01x
J0897Injection, denosumab, 1 mg291.5K$4.3M$14.872.24x
J9299Injection, nivolumab, 1 mg140.8K$3.2M$22.722.91x
J9310Injection, rituximab, 100 mg4.5K$2.8M$615.711.32x
J1569Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg72.1K$2.3M$32.412.21x
J9312Injection, rituximab, 10 mg27.7K$2.0M$72.202.25x
J0885Injection, epoetin alfa, (for non-esrd use), 1000 units177.6K$1.5M$8.472.48x
J9035Injection, bevacizumab, 10 mg21.8K$1.2M$56.621.45x
J1568Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg32.0K$1.1M$32.882.89x
99214Established patient office or other outpatient visit, 30-39 minutes11.0K$997.9K$90.952.43x
96413Administration of chemotherapy into vein, 1 hour or less7.8K$906.9K$116.482.41x
J1439Injection, ferric carboxymaltose, 1 mg1.0M$867.0K$0.852.35x
99213Established patient office or other outpatient visit, 20-29 minutes11.6K$684.2K$58.772.15x
Q5118Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg18.7K$614.5K$32.834.37x
J9395Injection, fulvestrant, 25 mg14.8K$612.4K$41.243.01x
J9041Injection, bortezomib (velcade), 0.1 mg14.3K$501.5K$35.152.40x
J9055Injection, cetuximab, 10 mg9.8K$437.7K$44.801.67x
96365Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less6.5K$375.8K$57.822.35x
J2505Injection, pegfilgrastim, 6 mg100$340.2K$3.4K1.45x
99205New patient office or other outpatient visit, 60-74 minutes1.7K$275.4K$164.242.10x

Markup Analysis

Charge-to-Payment Ratio

2.49x

This provider submits charges 2.49 times higher than what Medicare actually pays.

What This Means

A markup ratio of 2.49x means for every $100 Medicare pays, this provider initially charges $249. This is higher than the national average.

Location

Rancho Mirage, CA

Provider Verification

Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.

Similar Providers

Other Hematology-Oncology providers in CA for peer comparison.

Amy Law (you)
$34.4M
Luke Dreisbach, M.D.
$77.2M
Sachin Gupta, M.D.
$55.1M
Ravi Rao, MDโš ๏ธ
$49.1M
Michael Sherman, M.D., PHD
$38.9M
Nerses Tchekmedyian, M.D.
$38.0M
Show detailed table โ–พ
ProviderLocationTotal PaymentsStatus
Luke Dreisbach, M.D.Rancho Mirage, CA$77.2Mโœ“ Clear
Sachin Gupta, M.D.Fresno, CA$55.1Mโœ“ Clear
Ravi Rao, MDFresno, CA$49.1Mโš ๏ธ Flagged
Michael Sherman, M.D., PHDWalnut Creek, CA$38.9Mโœ“ Clear
Nerses Tchekmedyian, M.D.Irvine, CA$38.0Mโœ“ Clear

Related

Browse
โ† Back to Provider Directory
State
All providers in CA โ†’
Specialty
All Hematology-Oncology providers โ†’
Tool
Compare this provider โ†’
Analysis
Fraud Watchlist โ†’
Search
Search all providers โ†’

Share This Provider

Share this provider's Medicare payment information

Share:

Data Sources

  • โ€ข Centers for Medicare & Medicaid Services (CMS)
  • โ€ข Medicare Provider Utilization and Payment Data (2014-2023)
  • โ€ข National Plan and Provider Enumeration System (NPPES)

Last Updated: February 2026 (data through 2023, the latest CMS release)

Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.

Believe this data is inaccurate? Dispute this data